2 recruiting, 1 active not recruiting, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Active not recruiting 1 |
Follow T cell immunodeficiency primary: new trials by email Literature Review of T cell immunodeficiency primary trials Research Report on T cell immunodeficiency primary
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity Busulfan test dose, Fludarabine, Busulfan - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Recruiting | National Cancer Institute (NCI) | 66 | 2020-09-22 | 2026-10-19 |
| Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation e-ATG, Immunosuppression Only Conditioning, Reduced Intensity Conditioning - Lymphoproliferative Disorders, Autoimmune Lymphoproliferative | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 71 | 2018-09-04 | 2026-03-17 |
| Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency | Completed | National Cancer Institute (NCI) | 161 | 2017-06-14 | 2020-02-21 | |
| Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditioning-Closed with amendment L - Primary T-cell Immunodeficiency Disorders, Common Variable Immunodeficiency | Phase 2 | Recruiting | National Cancer Institute (NCI) | 354 | 2015-11-19 | 2026-11-05 |
Common Variable Immunodeficiency (4) · Autoimmune Diseases (3) · Immune System Diseases (3) · Lymphoproliferative Disorders (3) · Opportunistic Infections (3) · Immunologic Deficiency Syndromes (1)
Hemic and Lymphatic Diseases (3) · Immunologic Deficiency Syndromes (3) · Immunoproliferative Disorders (3) · Infections (3) · Lymphatic Diseases (3) · Immune System Diseases (1)
Busulfan (2) · Cyclophosphamide (2) · Mycophenolic Acid (2) · Tacrolimus (2) · Absorptiometry, Photon (1) · Alemtuzumab (1) · Antilymphocyte Serum (1) · Biopsy (1) · Electrocardiography (1) · Mesna (1) · Pentostatin (1) · Prednisone (1) · Respiratory Function Tests (1) · Whole-Body Irradiation (1) · fludarabine (1)
National Cancer Institute (NCI) (4)
United States (4)
Dimana Dimitrova, M.D. (2) · Jennifer A Kanakry, M.D. (1) · Sung-Yun Pai, M.D. (1)